Helminthiases could also limit the usefulness of type 2 asthma markers such as total IgE, fractional exhaled nitric oxide (FeNO), and blood eosinophils, which can impact decisions regarding the use of biologics for treatment. This evidence concerns the gene IGHE and echinococcosis.